An interventional study of surgical treatment in Bone Diseases, sponsored by Children's Hospital of Chongqing Medical University. Completed. Open to participants aged 4 Years to 9 Years. Per ClinicalTrials.gov, last updated 2016-11-25.
Sponsored by Children's Hospital of Chongqing Medical University · Not applicable, Interventional, and Treatment
Localization of small femur lesions for resection can be challenging and may be associated with the need for significant fluoroscopic imaging and tissue dissection.
This study was performed to evaluate the use of a radiopaque localizer grid along with methylene blue staining for resection of small femur lesions in children, and to determine this technique's effectiveness at reducing radiation exposure and tissue injury.
261 studies on the registry are indexed under Bone Diseases; 49 are open to participants now.
This study's enrollment of 40 is below the median of 54 across 148 interventional studies indexed under Bone Diseases.
Browse Bone Diseases studies →Children's Hospital of Chongqing Medical University is the lead sponsor of 35 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The dissection was continued into the deeper layers until the bone lesion was visualized, and the bone lesion was then thoroughly resected.
Radiation: surgical treatment
Use of a radiopaque localizer grid and methylene blue staining as an aid to resect the lesions
The times of C-arm fluoroscopy used
Time frame: intraoperative
incision length
Time frame: intraoperative
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital of Chongqing Medical University